Biography of Beverley Carr
Last update: March 6, 2024Career
Beverley was Vice President, Business Development Immunoinflammation and Dermatology at GSK, and Chief Business Officer and Director at Tempero Pharmaceuticals.
Beverley Carr is currently Interim Chief Executive Officer, Chief Business and Operating Officer at Amphista Therapeutics - View - Amphista Therapeutics org chart
Create your alert
to follow the career of Beverley Carr.
Education
Beverley Carr has a PhD in Organic Chemistry from University of Oxford in 1997 and a Master of Business Administration from University of Cambridge in 2001.
They have also studied at University of Oxford :
Find more alumni from University of Oxford
They have also studied at University of Cambridge :
Find more alumni from University of Cambridge
More about Beverley Carr
Do you need to know more about Beverley Carr? More results.
Participate
Social media
- Beverley Carr on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Beverley Carr
The colleagues of Beverley Carr
Company Colleagues
- At Amphista Therapeutics, Beverley Carr has 16 colleagues including Rogier Rooswinkel (Director), Dominic Schmidt (Director)…
Industry Colleagues
- In the Biotechnology industry, Beverley Carr has 30,413 colleagues in 2,292 companies located in 38 countries. 14,221 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Beverley Carr.
Get in Touch
Sorry, but Beverley Carr cannot be contacted yet through our email service. Please use our Premium/VIP service to join colleagues of Beverley Carr listed below. Here are a few tips for establishing great contacts.
